Literature DB >> 19907034

Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.

Mariana Baz, Yacine Abed, Jesse Papenburg, Xavier Bouhy, Marie-Eve Hamelin, Guy Boivin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19907034     DOI： 10.1056/NEJMc0910060

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  90 in total

Review 1.  Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.

Authors:  Nicolas Widmer; Pascal Meylan; Anton Ivanyuk; Manel Aouri; Laurent A Decosterd; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2010-11       Impact factor: 6.447

Review 2.  The 2009 influenza A (H1N1) pandemic: what have we learned in the past 6 months.

Authors:  Carlos del Rio; Jeannette Guarner
Journal:  Trans Am Clin Climatol Assoc       Date:  2010

3.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.

Authors:  Andrés Pizzorno; Xavier Bouhy; Yacine Abed; Guy Boivin
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

4.  A preliminary study on the medical expenditure of Chinese medicine and integrative medicine treatment for influenza A (H1N1) in the fever clinics.

Authors:  Chuan-jian Lu; Yi Luo; Hong Zhou; Xiao-lan Qin; Bo-jun Chen; Xue-chun Tang; Hua Deng; Zhao-hui Liang; Ai-hua Ou
Journal:  Chin J Integr Med       Date:  2010-11-26       Impact factor: 1.978

5.  Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance.

Authors:  Elodie Ghedin; Jennifer Laplante; Jay DePasse; David E Wentworth; Roberto P Santos; Martha L Lepow; Joanne Porter; Kathleen Stellrecht; Xudong Lin; Darwin Operario; Sara Griesemer; Adam Fitch; Rebecca A Halpin; Timothy B Stockwell; David J Spiro; Edward C Holmes; Kirsten St George
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

6.  2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients.

Authors:  Carrye Cost; Evangeline Brock; Beverley Adams-Huet; Jane D Siegel; Monica I Ardura
Journal:  Pediatr Blood Cancer       Date:  2011-01       Impact factor: 3.167

7.  Pandemic Influenza A H1N1 (2009) Virus: Lessons from the Past and Implications for the Future.

Authors:  Madhu Khanna; Binod Kumar; Ankit Gupta; Prashant Kumar
Journal:  Indian J Virol       Date:  2012-03-25

8.  Exploring organosilane amines as potent inhibitors and structural probes of influenza a virus M2 proton channel.

Authors:  Jun Wang; Chunlong Ma; Yibing Wu; Robert A Lamb; Lawrence H Pinto; William F DeGrado
Journal:  J Am Chem Soc       Date:  2011-08-12       Impact factor: 15.419

9.  Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.

Authors:  Xin Zhao; Runfeng Li; Yang Zhou; Mengjie Xiao; Chunlong Ma; Zhongjin Yang; Shaogao Zeng; Qiuling Du; Chunguang Yang; Haiming Jiang; Yanmei Hu; Kefeng Wang; Chris Ka Pun Mok; Ping Sun; Jianghong Dong; Wei Cui; Jun Wang; Yaoquan Tu; Zifeng Yang; Wenhui Hu
Journal:  J Med Chem       Date:  2018-06-11       Impact factor: 7.446

10.  Management of respiratory viral infections in hematopoietic cell transplant recipients.

Authors:  Dimpy P Shah; Shashank S Ghantoji; Victor E Mulanovich; Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Am J Blood Res       Date:  2012-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.